from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3196/-

LFCtreatmentdescriptionclass of inhibitor

-0.231

Amikacinug/mL Amikacintranslation

1.013

Cap5-10ug/mL Capreomycintranslation

0.904

Rox10-50 ug/mL Roxithromycintranslation

-0.728

SM2-5 ug/mL Streptomycintranslation

1.842

Tet5-10 ug/mL Tetracyclinetranslation

0.240

Rif0.2-5ug/mL Rifampicintranscription

-0.248

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.302

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.150

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.313

CPZ10-50 ug/mL Chlorpromazinerespiration

0.417

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.378

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.207

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.326

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.016

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.366

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.297

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.366

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.697

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.491

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.126

KCN5-20 ug/mL Potassium cyaniderespiration

0.143

NaN30.2-2 mM Sodium aziderespiration

-0.944

Nigericin50 uM Nigericinrespiration

0.510

TRC10-150 ug/mL Triclosanrespiration

1.206

TRZ10-25 ug/mL Thioridazinerespiration

1.123

Valinomycin0.5-10 uM Valinomycinrespiration

-0.979

ZnSO42 mM ZnSO4respiration

0.408

menadione6-10 ug/mL Menadionerespiration

0.778

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.011

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.997

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.571

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.535

NRP_1Non-replicating persistence stage 1dosRassociated

-0.822

Amp0.2mg/mL AmpicillincellWall

-0.549

Cephalexin20-100 ug/mL CephalexincellWall

-0.175

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.590

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.452

EMB10-20 ug/mL EthambutolcellWall

-0.839

Eta12-40 ug/mL EthionamidecellWall

-0.568

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.429

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.050

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.560

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.093

BZA0.12 mg/mL BenzamidearomaticAmides

-0.596

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.423

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.764

H2O24 mM hydrogen peroxideDNAdamaging

0.264

Levo10 ug/mL LevofloxacinDNAdamaging

-0.513

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.036

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.292

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.232

UVUV-irradiationDNAdamaging

2.376

ARP41-4 ug/mL Antitubercular compound ARP4?

0.381

Antimycin12.5-50 ug/mL Antimycin A?

-1.130

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.229

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.234

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.081

PA8240.2-2 ug/mL PA-824?

0.828

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.665

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.699

Verapamil50 uM Verapamil?

-0.667

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.683

methoxatin10-20 ug/mL Methoxatin?